A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs
Journal of Veterinary Internal Medicine · 01.07.2024 · 38 (4) · 2120-2128
DOI: 10.1111/jvim.17106 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.07.2024. Verfasst von Antonio Maria Tardo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Insulin Glargine, Dog Diseases, Hypoglycemic Agents, Diabetes Mellitus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
In purpose-bred dogs, insulin glargine 300 U/mL (IGla300) has long duration of action, peakless time-action profile, and low potency, making it suitable for use as a basal insulin. Hypothesis To evaluate IGla300 in client-owned diabetic dogs monitored using a flash glucose monitoring system (FGMS). Animals Ninety-five client-owned diabetic dogs, newly diagnosed or previously treated with other insulin formulations, with or without concurrent diseases.
Methods
Prospective multi-institutional study. Clinical signs and standardized assessment of FGMS data, using treatment and monitoring guidelines established a priori, guided dose adjustments and categorization into levels of glycemic control.
Results
The initial IGla300 dose was 0.5 U/Kg q24h for newly diagnosed dogs and (median dose [range]) 0.8 U/Kg (0.2-2.5) q24h for all dogs. Glycemic control was classified as good or excellent in 87/95 (92%) dogs. The IGla300 was administered q24h (1.9 U/kg [0.2-5.2]) and q12h (1.9 U/kg/day [0.6-5.0]) in 56/95 (59%) and 39/95 (41%) dogs, respectively. Meal-time bolus injections were added in 5 dogs (0.5 U/kg/injection [0.3-1.0]). Clinical hypoglycemia occurred in 6/95 (6%) dogs. Dogs without concurrent diseases were more likely to receive IGla300 q24h than dogs with concurrent diseases (72% vs 50%, respectively; P = .04). Conclusions and Clinical Importance Insulin glargine 300 U/mL can be considered a suitable therapeutic option for once-daily administration in diabetic dogs. Clinicians should be aware of the low potency and wide dose range of IGla300. In some dogs, twice-daily administration with or without meal-time bolus injections may be necessary to achieve glycemic control. Monitoring with FGMS is essential for dose titration of IGla300.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
- Animal Diabetes Australia, Collingwood, Victoria, Australia.
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
- BluePearl Pet Hospital, Rockville, Maryland, USA.
ORCID-Profile: Antonio Maria Tardo, Federico Fracassi, Aria L Guarino, Chen Gilor
Zitieren
APA
Tardo, A. M., Fleeman, L. M., Fracassi, F., Berg, A. S., Guarino, A. L., & Gilor, C. (2024). A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs. Journal of Veterinary Internal Medicine, 38(4), 2120-2128. https://doi.org/10.1111/jvim.17106
Vancouver
Tardo AM, Fleeman LM, Fracassi F, Berg AS, Guarino AL, Gilor C. A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs. Journal of Veterinary Internal Medicine. 2024;38(4):2120-2128. doi:10.1111/jvim.17106
BibTeX
@article{Tardo2024,
author = {Tardo, Antonio Maria and Fleeman, Linda Mary and Fracassi, Federico and Berg, Alisa Saule and Guarino, Aria L and Gilor, Chen},
title = {A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
volume = {38},
number = {4},
pages = {2120--2128},
doi = {10.1111/jvim.17106}
}
EUVIMED